Research & Development



  但是,對一個常年在戰場上廝殺的老變態來說,他不會理睬你這些的,只要你敢在戰場上背著同袍逃跑,他就真的敢舉起刀子殺人!   李敢收起自己的大弓吧嗒吧嗒嘴巴道︰“有錢好啊,老子做夢都想成為有錢人,可就是沒錢啊。阿襄,我的斬獲多,要不你再拿走一些,回去了幫我把莊子擴一下。”青青草av   有了一個新加入的苦力,即便是屁股上被匈奴人削掉二兩肉的謝寧也倍覺輕松。在线av   三年後的霍去病或許是……十年後的趙破奴或許也是!   騎都尉的伙夫盡量不去招惹他們,在這群人等包子吃的功夫,拎來了好幾桶小米湯。av在线视频   漢人的弩箭不僅射的遠,而且還鋒利,五十步以內,即便是輕薄的鐵甲都能貫穿,至于大多數羌人裝備的皮甲,在三菱錐面前如同薄絹。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo